Montalban X, Hohlfeld R, Pozzilli C, Freedman MS, et al. Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study. J Neurol 2026;273:234.
PMID: 41879928